Erythrocin Stearate (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the Erythrocin Stearate drug offered from KAISER FOUNDATION HOSPITALS. This Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
| NON-PROPRIETARY NAME: | ERYTHROMYCIN STEARATE |
| SUBSTANCE NAME: | ERYTHROMYCIN STEARATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-01-06 |
| END MARKETING DATE: | 0000-00-00 |
Erythrocin Stearate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Erythrocin Stearate from KAISER FOUNDATION HOSPITALS |
| LABELER NAME: | KAISER FOUNDATION HOSPITALS |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2012-01-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0179-0105_2118df83-73ab-4150-babc-8b48aacd80af |
| PRODUCT NDC: | 0179-0105 |
| APPLICATION NUMBER: | ANDA060359 |
Other ERYTHROMYCIN STEARATE Pharmaceutical Manufacturers / Labelers:
